The AhR agonist VAF347 augments retinoic acid-induced differentiation in leukemia cells.
In binary cell-fate decisions, driving one lineage and suppressing the other are conjoined. We have previously reported that aryl hydrocarbon receptor (AhR) promotes retinoic acid (RA)-induced granulocytic differentiation of lineage bipotent HL-60 myeloblastic leukemia cells. VAF347, an AhR agonist, impairs the development of CD14(+)CD11b(+) monocytes from granulo-monocytic (GM) stage precursors. We thus hypothesized that VAF347 propels RA-induced granulocytic differentiation and impairs D3-induced monocytic differentiation of HL-60 cells. Our results show that VAF347 enhanced RA-induced cell cycle arrest, CD11b integrin expression and neutrophil respiratory burst. Granulocytic differentiation is known to be driven by MAPK signaling events regulated by Fgr and Lyn Src-family kinases, the CD38 cell membrane receptor, the Vav1 GEF, the c-Cbl adaptor, as well as AhR, all of which are embodied in a putative signalsome. We found that the VAF347 AhR ligand regulates the signalsome. VAF347 augments RA-induced expression of AhR, Lyn, Vav1, and c-Cbl as well as p47(phox). Several interactions of partners in the signalsome appear to be enhanced: Fgr interaction with c-Cbl, CD38, and with pS259c-Raf and AhR interaction with c-Cbl and Lyn. Thus, we report that, while VAF347 impedes monocytic differentiation induced by 1,25-dihydroxyvitamin D3, VAF347 promotes RA-induced differentiation. This effect seems to involve but not to be limited to Lyn, Vav1, c-Cbl, AhR, and Fgr.
Department of Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA.
Christopher N
CN
Ibabao
Department of Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA.
Rodica P
RP
Bunaciu
Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY 14853, USA.
Deanna M W
DM
Schaefer
Department of Biomedical Sciences, Cornell University, Ithaca, NY 14853, USA.
Andrew
A
Yen
APC, allophycocyanin; APL, acute promyelocytic leukemia; AhR, aryl hydrocarbon receptor; D3, 1,25-dihydroxyvitamin D3; Differentiation; FICZ, 6-formylindolo (3,2-b) carbazole; GM, granulo-monocytic; Leukemia; PE, phycoerythrin; RA, all trans-retinoic acid; Retinoic acid; TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin; VAF347; VAF347, (4-(3-Chloro-phenyl)-pyrimidin-2-yl)-(4-trifluoromethyl-phenyl)-amine